Centricity Research

London, Ontario N6A 2C2

0 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis, Plaque Psoriasis

Studies at this site

• A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis — Completed